News Feed Opinion Blog Posts Career Updates Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
September, 2025
September 2025
M T W T F S S
1234567
891011121314
15161718192021
22232425262728
2930  
Winan van Houdt: Rare cutaneous cancers session at the annual meeting of EADV
Photo of Winan van Houdt from eventscribe.net
Sep 30, 2024, 19:16

Winan van Houdt: Rare cutaneous cancers session at the annual meeting of EADV

Winan van Houdt, Surgical Oncologist at Antoni van Leeuwenhoek/the Netherlands Cancer Institute, shared a post on LinkedIn:

“Lecturing in the rare cutaneous cancers session at the annual meeting of the European dermatology society EADV addressing open questions about the treatment of the Dermato Fibrosarcoma Protuberans (DFSP) – at the RAI in our own Amsterdam.”

Winan van Houdt: Rare cutaneous cancers session at the annual meeting of EADV

Source: Winan van Houdt/LinkedIn

cancer cancer awareness cancer care Dermato Fibrosarcoma Protuberans (DFSP) EADV fight against cancer Global fight against cancer OncoDaily Oncology Winan van Houdt
Special Coverage
Science
Sep 3, 2025, 10:50
Jordi Remon: PECATI Trial - Lenvatinib Plus Pembrolizumab in Metastatic B3-Thymoma and Thymic Carcinoma
Voices
Sep 3, 2025, 10:35
From Shorter Treatments to Personalised Strategies - ESTRO
Voices
Sep 3, 2025, 10:27
Gerry Hanna: 20 Years of Progress and Future Goals in Cancer Care Across Europe
Science
Sep 3, 2025, 10:22
Pierre Blanchard: Another Proof That Metastasis-Directed Therapy Improves Outcomes
Voices
Sep 3, 2025, 10:18
Powerful Actions Driving Change in Childhood Cancer Care - SIOP
Voices
Sep 3, 2025, 10:08
Rafael Fonseca: Classifying Myeloma Treatments as Curative Versus Control Ones
Insight
Sep 3, 2025, 10:07
Oncia Community is hosting a Free Webinar on the Role of Nutrition in Cancer Care
Science
Sep 3, 2025, 10:07
C. Jillian Tsai: Comprehensive Guidelines in Nasopharyngeal Carcinoma Radiotherapy
Insight
Sep 3, 2025, 10:03
Miguel Bronchud: Key Takeaways from Kerstin N. Vokinger on Oncology Drug Innovation and Regulatory Strategy
Insight
Sep 3, 2025, 09:59
Rishabh Jain: FGFR1 Joins the Club of High-Risk CRC Alterations
Voices
Sep 3, 2025, 09:57
Joshua Omale: Why Gold is the Color of Childhood Cancer Awareness?
Voices
Sep 3, 2025, 09:53
Fahad Alkaabba: Overview of Management of Localized NSCLC